hlx07
Showing 1 - 9 of 9
HLX07, nsqNSCLC, High EGFR Expression Trial in Shanghai (HLX07+carboplatin+pemetrexed, HLX07+docetaxel, HLX07)
Not yet recruiting
- HLX07, nsqNSCLC, High EGFR Expression
- HLX07+carboplatin+pemetrexed
- +2 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 5, 2022
CRC Trial (HLX07, HLX10, mFOLFOX6)
Not yet recruiting
- CRC
- HLX07
- +2 more
- (no location specified)
May 1, 2022
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Wuwei, Shanghai (HLX07+HLX10+oxaliplatin+capecitabine,
Recruiting
- Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
-
Wuwei, Gansu, China
- +1 more
Apr 25, 2022
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- HLX07
- +3 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 23, 2022
Advanced Hepatocellular Carcinoma Trial (HLX07, HLX10, HLX04)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- HLX07
- +3 more
- (no location specified)
May 1, 2022
Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- HLX07
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Jun 15, 2022
Solid Tumor Trial in Shanghai (HLX07)
Not yet recruiting
- Solid Tumor
- HLX07
-
Shanghai, ChinaFudan University shanghai cancer center
May 3, 2022
Small-cell Lung Cancer Trial in Changchun (HLX07, HLX10, carboplatin and etoposide)
Not yet recruiting
- Small-cell Lung Cancer
- HLX07
- +2 more
-
Changchun, Jilin, ChinaJilin Cancer Hospital
May 3, 2022
ESCC or Esophageal Adenosquamous Carcinoma Trial in Guangzhou (HLX07+HLX10+ Cisplatin+5-FU, HLX07)
Recruiting
- ESCC or Esophageal Adenosquamous Carcinoma
- HLX07+HLX10+ Cisplatin+5-FU
- HLX07
-
Beijing, Beijing, China
- +16 more
Aug 25, 2022